$704 Million is the total value of ORACLE INVESTMENT MANAGEMENT INC's 32 reported holdings in Q4 2021. The portfolio turnover from Q3 2021 to Q4 2021 was 80.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
BHVN | Sell | BIOHAVEN PHARMACTL HLDG CO L | $286,011,000 | -3.1% | 2,075,402 | -2.3% | 40.64% | +10.6% |
QDEL | Sell | QUIDEL CORP | $115,426,000 | -9.8% | 855,068 | -5.7% | 16.40% | +2.9% |
OPK | Sell | OPKO HEALTH INC | $58,774,000 | +25.6% | 12,219,073 | -4.7% | 8.35% | +43.4% |
VIR | Sell | VIR BIOTECHNOLOGY INC | $36,050,000 | -29.9% | 861,008 | -27.1% | 5.12% | -20.0% |
AGEN | Sell | AGENUS INC | $29,322,000 | -40.8% | 9,106,132 | -3.5% | 4.17% | -32.4% |
PACB | Sell | PACIFIC BIOSCIENCES CALIF IN | $29,120,000 | -21.1% | 1,420,652 | -1.7% | 4.14% | -10.0% |
PFE | New | PFIZER INC | $28,049,000 | – | 475,000 | +100.0% | 3.99% | – |
BCRX | Sell | BIOCRYST PHARMACEUTICALS INC | $23,140,000 | -16.2% | 1,670,733 | -13.0% | 3.29% | -4.3% |
AXDX | Sell | ACCELERATE DIAGNOSTICS INC | $18,936,000 | -13.4% | 3,627,549 | -3.3% | 2.69% | -1.2% |
PFE | New | PFIZER INCput | $15,041,000 | – | 1,400,000 | +100.0% | 2.14% | – |
FORA | Buy | FORIAN INC | $11,001,000 | -11.2% | 1,219,661 | +1.6% | 1.56% | +1.4% |
AWH | Sell | ASPIRA WOMENS HEALTH INC | $9,818,000 | -65.1% | 5,547,094 | -35.9% | 1.40% | -60.1% |
Sell | DERMTECH INC | $9,526,000 | -51.5% | 602,907 | -1.5% | 1.35% | -44.7% | |
CDAK | Sell | CODIAK BIOSCIENCES INC | $7,343,000 | -35.8% | 659,191 | -5.8% | 1.04% | -26.7% |
ATRS | Sell | ANTARES PHARMA INC | $6,140,000 | -11.2% | 1,720,000 | -9.5% | 0.87% | +1.3% |
CFRX | Buy | CONTRAFECT CORP | $5,135,000 | -24.9% | 1,952,422 | +15.6% | 0.73% | -14.3% |
IMMP | Sell | IMMUTEP LTDsponsored ads | $3,202,000 | -17.3% | 976,156 | -2.4% | 0.46% | -5.6% |
CCRN | New | CROSS CTRY HEALTHCARE INC | $1,971,000 | – | 71,000 | +100.0% | 0.28% | – |
VIR | New | VIR BIOTECHNOLOGY INCput | $1,577,000 | – | 287,600 | +100.0% | 0.22% | – |
BCRX | New | BIOCRYST PHARMACEUTICALS INCput | $1,383,000 | – | 700,000 | +100.0% | 0.20% | – |
SPY | Buy | SPDR S&P 500 ETF TRput | $1,308,000 | -15.9% | 500,000 | +100.0% | 0.19% | -4.1% |
ARKG | New | ARK ETF TRput | $1,076,000 | – | 350,000 | +100.0% | 0.15% | – |
SLNO | SOLENO THERAPEUTICS INC | $874,000 | -55.7% | 2,132,000 | 0.0% | 0.12% | -49.4% | |
OPK | New | OPKO HEALTH INCput | $685,000 | – | 757,300 | +100.0% | 0.10% | – |
XBIT | New | XBIOTECH INCput | $674,000 | – | 500,000 | +100.0% | 0.10% | – |
BIIB | BIOGEN INC | $579,000 | -15.2% | 2,412 | 0.0% | 0.08% | -3.5% | |
CNC | New | CENTENE CORP DELput | $531,000 | – | 416,300 | +100.0% | 0.08% | – |
New | DERMTECH INCput | $425,000 | – | 250,000 | +100.0% | 0.06% | – | |
PTIX | Sell | PROTAGENIC THERAPEUTICS INC | $416,000 | -55.5% | 300,267 | -39.9% | 0.06% | -49.1% |
PACB | New | PACIFIC BIOSCIENCES CALIF INput | $126,000 | – | 67,000 | +100.0% | 0.02% | – |
MOTS | Sell | MOTUS GI HLDGS INC | $49,000 | -97.6% | 105,885 | -96.4% | 0.01% | -97.2% |
AGEN | New | AGENUS INCput | $22,000 | – | 298,300 | +100.0% | 0.00% | – |
PACB | Exit | PACIFIC BIOSCIENCES CALIF INcall | $0 | – | -43,700 | -100.0% | -0.01% | – |
AGEN | Exit | AGENUS INCcall | $0 | – | -100,000 | -100.0% | -0.01% | – |
PFE | Exit | PFIZER INCcall | $0 | – | -750,000 | -100.0% | -0.01% | – |
OPK | Exit | OPKO HEALTH INCcall | $0 | – | -473,800 | -100.0% | -0.02% | – |
BCRX | Exit | BIOCRYST PHARMACEUTICALS INCcall | $0 | – | -150,000 | -100.0% | -0.02% | – |
SEM | Exit | SELECT MED HLDGS CORPcall | $0 | – | -26,100 | -100.0% | -0.02% | – |
XBIT | Exit | XBIOTECH INC | $0 | – | -350,000 | -100.0% | -0.03% | – |
MDGL | Exit | MADRIGAL PHARMACEUTICALS INCcall | $0 | – | -63,000 | -100.0% | -0.05% | – |
VTNR | Exit | VERTEX ENERGY INC | $0 | – | -90,000 | -100.0% | -0.06% | – |
LLY | Exit | LILLY ELI & COcall | $0 | – | -100,000 | -100.0% | -0.08% | – |
QQQ | Exit | INVESCO QQQ TRput | $0 | – | -300,000 | -100.0% | -0.11% | – |
VIR | Exit | VIR BIOTECHNOLOGY INCcall | $0 | – | -383,700 | -100.0% | -0.15% | – |
BDSX | Exit | BIODESIX INC | $0 | – | -180,833 | -100.0% | -0.18% | – |
BHVN | Exit | BIOHAVEN PHARMACTL HLDG CO Lcall | $0 | – | -80,000 | -100.0% | -0.27% | – |
MDGL | Exit | MADRIGAL PHARMACEUTICALS INC | $0 | – | -38,500 | -100.0% | -0.38% | – |
AMRN | Exit | AMARIN CORP PLCspons adr new | $0 | – | -838,403 | -100.0% | -0.53% | – |
SEM | Exit | SELECT MED HLDGS CORP | $0 | – | -149,678 | -100.0% | -0.67% | – |
GH | Exit | GUARDANT HEALTH INC | $0 | – | -70,000 | -100.0% | -1.09% | – |
YMAB | Exit | Y-MABS THERAPEUTICS INC | $0 | – | -315,642 | -100.0% | -1.12% | – |
AVIR | Exit | ATEA PHARMACEUTICALS INC | $0 | – | -309,126 | -100.0% | -1.35% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-02-14
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
OPKO HEALTH INC | 42 | Q3 2023 | 10.6% |
PACIFIC BIOSCIENCES CALIF IN | 42 | Q3 2023 | 22.6% |
BIOGEN INC | 42 | Q3 2023 | 0.6% |
QUIDEL CORP | 36 | Q1 2022 | 52.5% |
AMARIN CORP PLC | 31 | Q3 2021 | 23.1% |
VERMILLION INC | 28 | Q1 2020 | 3.8% |
AGENUS INC | 25 | Q3 2023 | 9.8% |
TESARO INC | 23 | Q4 2018 | 27.8% |
ACCELERATE DIAGNOSTICS INC | 23 | Q2 2023 | 23.0% |
MAZOR ROBOTICS LTD | 20 | Q1 2018 | 18.0% |
View ORACLE INVESTMENT MANAGEMENT INC's complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-02-14 |
13F-HR | 2023-11-14 |
13F-HR | 2023-08-14 |
13F-HR | 2023-05-15 |
13F-HR | 2023-02-14 |
13F-HR | 2022-11-14 |
13F-HR | 2022-08-15 |
13F-HR | 2022-05-16 |
13F-HR | 2022-02-14 |
13F-HR | 2021-11-15 |
View ORACLE INVESTMENT MANAGEMENT INC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.